Completed NA INTERVENTIONAL 3-arm NCT00645918

GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety (GRAVITAS)

Sponsor: Accumetrics, Inc.

Conditions Acute Coronary Syndrome Coronary Arteriosclerosis

Updated 7 times since 2017 Last updated: Jun 15, 2011 Started: Jun 30, 2008 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Coronary Syndrome and Coronary Arteriosclerosis and is currently completed. Accumetrics, Inc. leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Accumetrics, Inc.

Data source: Accumetrics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anderson, United States , Atlanta, United States , Austin, United States , Baltimore, United States , Birmingham, United States , Boston, United States , Bridgeport, United States , Burlington, United States , Charleston, United States , Chicago, United States and 58 more locations